In 2020, Melazzini et al. first reported that compared with COVID-19 patients without VTE, the increased inflammatory indicators and serum proinflammatory cytokines, especially IL-6, should not be overlooked among those with VTE [25]. This evidence concerns the gene IL6 and COVID-19.